A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.
Clinical trial NCT04543357 · TERMINATED
Trial details
- NCT number
- NCT04543357
- Sponsor
- Pfizer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-17
- Primary completion
- 2024-02-27
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.